Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
About this item
Full title
Author / Creator
Publisher
Berlin: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Berlin: Springer
Subjects
More information
Scope and Contents
Contents
Dendritic cell (DC)-based immunotherapy is a promising approach to augment tumor antigen-specific T cell responses in cancer patients. However, tumor escape with down-regulation or complete loss of target antigens may limit the susceptibility of tumor cells to the immune attack. Concomitant generation of T cell responses against several immunodomin...
Alternative Titles
Full title
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11031118
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11031118
Other Identifiers
ISSN
0340-7004
E-ISSN
1432-0851,1365-2567
DOI
10.1007/s00262-006-0157-3
